STAT5A and acute myeloid leukemia: PPARα/γ ligand derivatives, and in particular compound 17f, which is characterized by a free nitrogen on the indole ring along with a C-6 tetrahydroquinoline 3-pyridinyl substitution, selectively inhibited STAT5 activity, resulting in an antiproliferative effect against AML cellular models [93].